FYMRALIN Trademark Information

Trademark by TONIX PHARMACEUTICALS, INC.

Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric-related diseases and disorders

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: FYMRALIN
Status/Status Date:
FOURTH EXTENSION - GRANTED
6/25/2021
Serial Number: 88064191
Filing Date: 8/3/2018
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric-related diseases and disorders
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 12/25/2018
Last Applicant/Owner:
TONIX PHARMACEUTICALS, INC.
New York, NY 10022
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
WIGGIN AND DANA LLP
ONE CENTURY TOWER, 265 Church Street
NEW HAVEN CT 06510
Current Status:
FOURTH EXTENSION - GRANTED
6/25/2021
Correspondent Search:
FRANCIS J. DUFFIN is a correspondent of FYMRALIN trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on